• Aucun résultat trouvé

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial

N/A
N/A
Protected

Academic year: 2021

Partager "HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial"

Copied!
10
0
0

Texte intégral

Figure

Fig. 1 Study fl ow fl ow-chart of enrolment, allocation and analysis process in HIV vaccine Phase 2, double-blind, dose-ranging studyV

Références

Documents relatifs

(a) Standard deviation of the phase difference between consecutive samples as a function of the distance D, for B = 100 MHz. very close to the asymptotic limit) as a function of

For each predefined threshold-value of the ratio, sensitivity and specificity regarding a definite diagnosis of MF or BLC were calculated, taking into account that: a true

87 Human milk also contains bioactive proteins such as lactoferrin (present at higher concentration in human milk compared to IF), 88 hormones and cytokines

même que James s’interroge encore sur le privilège de son frère, sur l’identité de ces compagnons auxquels il n’a pas accès, il exerce de son côté une tout autre

(b) Measured decay histogram in three different situations: bead not coupled to a nanowire (blue), bead coupled to a nanowire and excited directly by the laser (green), same

The third study uses a mixed-method approach, combining a smartphone-based ambulatory assessment with an observational approach to examine whether high or low levels of

 ISSEA, Institut Sous-régional de Statistique et d'Économie Appliquée de Yaoundé  ENSAE, École Nationale de la Statistique et de l'Analyse Économique de Dakar  ENEAM,

Midi Minuit 1:00 AM MathsLibres.com... Midi Minuit 1:00